Court Backs Drug Cos. In Suicide Cases

Law360, New York (April 9, 2008, 12:00 AM EDT) -- The U.S. Court of Appeals for the Third Circuit has ruled that federal guidelines on drug warning labels trump state law in a case involving two people who committed suicide while taking antidepressants.

The families of the deceased sued GlaxoSmithKline and Pfizer under state failure-to-warn laws. Warning labels on Paxil and Zoloft did not include strong enough warnings about the risk of suicide and worsening depression, they said.

In a 2-1 decision, the appeals court rejected that argument Tuesday. It ruled that the drugmakers could not...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.